Journal of thrombosis and haemostasis : JTHHumansInfantRetrospective StudiesChildPreschool
Concizumab use in toddlers with hemophilia B and inhibitors real-world data from an international collaboration.
Sarina Levy-Mendelovich, Judith Timmermans, Beatrice Nolan, Sabina Heine, Federica Achini-Gutzwiller, Allison P Wheeler, Gili Kenet
Published: 202610.1016/j.jtha.2025.09.038
Abstract
BACKGROUND: Hemophilia B (HB) with inhibitors presents a treatment challenge, particularly in young children who may also experience allergic reactions to factor (F)IX. Concizumab, an antitissue factor pathway inhibitor monoclonal antibody, is a nove…
Preview only. Read the full abstract at the source